6场半全场中几场才有奖
七乐彩开奖结果查询表 抢庄牌九官网 自由抢庄牛牛玩法介绍 七星彩历史开奖结果 大小双单技巧 注册就送彩金真实网站 pk10直播开奖赛车网站 快三分析计划软件手机版 网络百人牛牛能赢吗 江西新时时玩法 必赢计划软件安卓版 对于通比牛牛技巧 黑龙江时时开奖号 360彩票计划软件手机版 全天精准计划数据 重庆时时彩开奖结果
 
  About Jincheng
 
Conpany profile >>Jincheng >> 6场半全场中几场才有奖
Shandong Jincheng Pharmaceutical Group Co., Ltd.  (Hereafter named as”JINCHENG PHARM”, Stock code: 300233) was established in 2004 and successful launched in Shenzhen GEM Board on June, 2011. The company is honored as National High-New Technology Enterprise. It has three whole owned subsidiary companies—Shandong Jincheng Kerui Chemical Co.,Ltd., Shandong Huihai Pharmaceutical and Chemical Co.,Ltd. ,Shandong Jincheng Zhonghua Bio-Pharmaceutical Co.,Ltd. and four production bases.The company is dedicated to research and development, production and sales for III、IV Cephalosporin intermediates. In this field, the company has great advantage and established Post-Doctoral Scientific Research station and Enterprise Technical Center of Shandong Province. The company is one of the main suppliers who own obvious competitive advantage for cephalosporin intermediates in the world market. Moreover, the company has formed the High-New technical products chain from basic chemicals to pharmaceutical intermediates and  extend to special APIs and biopharmaceuticals through actively practices the development pattern of “Change the development mode, Adjust the structure”, improve the independent innovation ability and adjusts and optimize the industrial structure.